We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
  • ::COVID-19 COVERAGE::
  • INDUSTRY PRESS ROOM
  • SUBMISSIONS
  • MEDIA FILE
  • Create Account
  • Sign In
  • Sign Out
  • My Account
Free Newsletters
  • MAGAZINE
    • Current Issue
    • Archives
    • Digital Edition
    • Subscribe
    • Newsletters
  • STRATEGY
  • GLOBAL
  • LOGISTICS
  • MANUFACTURING
  • PROCUREMENT
  • VIDEO
    • News & Exclusives
    • Viewer Contributed
    • Upload your video
  • BLOGS & MORE
    • White Papers
    • Webcasts
    • Events
    • Blogs
      • SCQ Forum
      • Reflections
    • Mobile Apps
  • MAGAZINE
    • Current Issue
    • Archives
    • Digital Edition
    • Subscribe
    • Newsletters
  • STRATEGY
  • GLOBAL
  • LOGISTICS
  • MANUFACTURING
  • PROCUREMENT
  • VIDEO
    • News & Exclusives
    • Viewer Contributed
    • Upload your video
  • BLOGS & MORE
    • White Papers
    • Webcasts
    • Events
    • Blogs
      • SCQ Forum
      • Reflections
    • Mobile Apps
Home » Report: global manufacturing and sourcing raise risks for pharma industry
Forward Thinking

Report: global manufacturing and sourcing raise risks for pharma industry

November 23, 2010
Supply Chain Quarterly Staff
No Comments

Outsourced manufacturing and global sourcing of raw materials are exposing pharmaceutical companies to an increased threat of counterfeiting, intellectual property theft, and product contamination. That was one of the main findings in a recent study that examined pharmaceutical supply chains, including the outsourcing of drug development, sourcing, and manufacturing to developing nations. The survey, which was co-sponsored by PriceWaterhouseCoopers LLP and Axendia Inc., canvassed 112 industry executives from pharmaceutical, medical device, and biotechnology companies in 12 countries.

Three-fourths of respondents said their companies plan to increase their manufacturing outside of the United States. Yet executives at pharmaceutical and life sciences companies increasingly worry about supply lines as more of them begin manufacturing and sourcing drugs and medicines in emerging economies such as China, India, Mexico, and Brazil. Half of the survey respondents said that raw materials sourced outside the United States represented their supply chains' greatest vulnerability, while 61 percent viewed contaminated or nonconforming raw materials as the top supply chain threat over the next five years.

Limited supply chain visibility based on "snapshots in time" frustrated the survey respondents. Seventy-seven percent stated that their primary method for gaining visibility into their suppliers' practices is a periodic audit. Only 25 percent of those surveyed reported sharing common practices and information with suppliers, while a mere 3 percent said that they have access to suppliers' data in real time. Sixty-six percent said they can obtain a global view of their supply chain activity but they need to manually aggregate the data from multiple locations.

Track-and-trace technology to provide supply chain visibility is now available, but that doesn't mean most companies are using it. Respondents cited four obstacles to its adoption: cost, difficulty of implementation, lack of industry standards, and lack of regulatory requirements and guidance.

Until the industry implements systems that can provide real-time, global supply chain visibility—including information from suppliers, distributors, logistics service providers, and contract manufacturers—the report says, companies will find it difficult to ensure the safety and effectiveness of pharma and life sciences products.

To view the complete study findings, go to: www.pwc.com/us/supplychainsurvey.

  • Related Articles

    Sourcing internationally: Six risks, and how to mitigate them

    Report: Manufacturing execs say global recession is likely in 2020

    Report: logistics careers posted top-ten pay raise in 2017

Recent Articles by Supply Chain Quarterly Staff

Blasgen to retire as leader of CSCMP in March

Reports: Outlook calls for stronger supply chains

Gartner: 4 ways to compete with industry disruptors

You must login or register in order to post a comment.

Report Abusive Comment

Most Popular Articles

  • The 3PL industry: time to reset

  • Supply chain resiliency starts with supplier mapping

  • Freight market growth expected to slow in 2021

  • Seizing the helm

  • The Top Supply Chain Pains That You Should Address For a Healthier 2021

Featured Video

Be8de8b1 9bd3 48d6 9400 0bf476fd1f5d

Optimization Through Lean Management 

Viewer Contributed
Uncertain times can put a tremendous strain on your business’s people, processes and supply chains. However, operations can mitigate some of these factors by adopting lean management principles and instilling a culture of continuous improvement. Raymond Lean Management Manager of Solutions and Support Centers Keith...

FEATURED WHITE PAPERS

  • The Top Supply Chain Pains That You Should Address For a Healthier 2021

  • Research Report: New Rules for Supply Chain Insights, Collaboration and Overall Resiliency

  • Logistics 2030 – Navigating a Disruptive Decade (Year 2 Report)

View More

Subscribe to Supply Chain Quarterly

Get Your Subscription
  • SUBSCRIBE
  • E-NEWSLETTERS
  • ADVERTISING
  • CUSTOMER CARE
  • CONTACT
  • ABOUT
  • STAFF
  • PRIVACY POLICY

Copyright ©2021. All Rights ReservedDesign, CMS, Hosting & Web Development :: ePublishing